pharmaceutical companies Archives | Be Korea-savvy
Drugmakers Decide on Capital Spending

Drugmakers Decide on Capital Spending

SEOUL, Mar. 18 (Korea Bizwire) — Several South Korean pharmaceutical companies have decided to make new facility investments in a bid to hone their competitiveness, industry sources said Monday. The decisions, made at annual shareholder meetings, are seen as reflecting their efforts to streamline and expand infrastructure for research and development (R&D), as well as [...]

Drugmakers’ Technology Exports Reach 5.3 tln Won in 2018

Drugmakers’ Technology Exports Reach 5.3 tln Won in 2018

SEOUL, Jan. 22 (Korea Bizwire) — Exports of drug-manufacturing technologies by South Korean pharmaceutical and bio companies reached nearly 5.3 trillion won (US$4.7 billion) in 2018 thanks to their efforts to tap into overseas markets, government data showed Tuesday. According to the data by the Ministry of Health and Welfare, industry player Yuhan Corp. and [...]

Supreme Court Decision Puts S. Korean Pharmaceutical Companies at Risk

Supreme Court Decision Puts S. Korean Pharmaceutical Companies at Risk

SEOUL, Jan. 21 (Korea Bizwire) — South Korean pharmaceutical companies are expressing grave concern as a recent Supreme Court decision may freeze the development of certain incrementally modified drugs. For long, pharmaceutical companies in South Korea have been releasing modified drugs that change certain saline substances, the strength, and dosage regimen of the original drug [...]

Pharmaceutical Companies Fail to Meet Sales Permit Conditions

Pharmaceutical Companies Fail to Meet Sales Permit Conditions

SEOUL, Nov. 5 (Korea Bizwire) — Pharmaceutical companies are facing controversy as they were found to be avoiding manufacturing certain medicines for which authorities issued sales permits upon condition that they would be used for clinical trials on patients, if market reaction was ‘not good enough’. Rep. Jang Jeong-sook of the ruling Democratic Party, a [...]

Major Pharmaceuticals Expand R&D Spending in H1

Major Pharmaceuticals Expand R&D Spending in H1

SEOUL, Aug. 16 (Korea Bizwire) — Major South Korean pharmaceutical companies expanded their spending on research and development (R&D) during the first half this year, with Hanmi Pharmaceutical Co. allocating the most, industry data showed Wednesday. According to their semi-annual business reports, 10 out of the 15 drug companies spent more on R&D during the [...]